BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix, Inc. (NASDAQ: OCUL) announced today that it has commenced an underwritten public offering of 4,000,000 shares of its common stock. The offering consists of 3,200,000 shares being offered by the Compa…
Author: Business Wire
Ocata Therapeutics Receives Important New U.S. Patent for its RPE Therapy for Macular Degenerative Diseases
MARLBOROUGH, Mass.–(BUSINESS WIRE)–Ocata Therapeutics, Inc. (“Ocata” or “the Company”; NASDAQ: OCAT), a leader in the field of Regenerative Ophthalmology™, today announced that it continues to fortify the scope of protection covering its retinal pigment epithelium (RPE) transplant technology with the issuance by the United States Patent and Trademark Office (USPTO) of U.S. Patent No 9,045,732. This new patent further strengthens the Company’s comprehensive suite of intellectual property which
EYE TECH CARE Launches Its Operations in China as Part of Its International Expansion
RILLIEUX-LA-PAPE, France–(BUSINESS WIRE)–EYE TECH CARE launches its operations in China as part of its international expansion.
EYE TECH CARE Launches Its Operations in China as Part of Its International Expansion
RILLIEUX-LA-PAPE, France–(BUSINESS WIRE)–EYE TECH CARE launches its operations in China as part of its international expansion.
Bruker Introduces MALDI Tissuetyper™ Solution with New High Speed rapifleX™ MALDI-TOF MS System for Anatomical Pathology Research
ST. LOUIS–(BUSINESS WIRE)–At the 63rd ASMS Conference on Mass Spectrometry & Allied Topics (ASMS), Bruker (NASDAQ: BRKR) announced the launch of the novel MALDI Tissuetyper solution, based on the new rapifleX MALDI-TOF Mass Spectrometry system. The introduction of the revolutionary rapifleX as the new instrument platform for MALDI imaging anatomical pathology research further enhances Bruker’s leadership position for MALDI-TOF-based applications solutions. The new rapifleX system eliminat
Bruker Introduces Comprehensive Mycobacteria Library 3.0 for High-Performance MALDI Biotyper Mycobacteria Identification
NEW ORLEANS–(BUSINESS WIRE)–At the 115th General Meeting of the American Society for Microbiology, Bruker (NASDAQ: BRKR) announced a major version 3.0 expansion of the proven Mycobacteria Library for research use only on the MALDI Biotyper microbial …
Tyrogenex X-82 Poster Presentation at the 2015 American Society for Clinical Oncology (ASCO) Annual Meeting
PALM BEACH GARDENS, Fla.–(BUSINESS WIRE)–Tyrogenex, a leader in the development of novel kinase inhibitors to target angiogenesis, announced that the University of Wisconsin presented a new trial concept of X-82 poster at ASCO in Chicago.
Second Sight to Present at Investor Conference on June 4, 2015
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics to provide functional vision to blind patients, today announced that the Company will present at the Three Part Advisors East Coast IDEAS Conference, as follows: Presentation Date: Thursday, June 4, 2015 Presentation Time: 3:10 p.m. EDT Location: Boston Park Plaza, Boston, MA The presentation will be we
Research and Markets: Keratoconjunctivitis sicca (Dry Eye) – Pipeline Review, H1 2015
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/mn2tbt/keratoconjunctivit) has announced the addition of the “Keratoconjunctivitis sicca (Dry Eye) – Pipeline Review, H1 2015” report to their offering. This repo…
Aerie Pharmaceuticals to Participate in Two Investor Conferences in June
IRVINE, Calif. & BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (Nasdaq:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye, announced today that Vicente Anido, Jr., Ph.D., Chief Executive Officer and Chairman of the Board, will present an overview of the company at the following conferences in
Doctors Embrace Avenova™ for Common Eye Conditions
SAN RAFAEL, Calif.–(BUSINESS WIRE)–The Eye Institute, located in Marin County, California, announced today that an informal survey of eye doctors shows a major surge in the use of Avenova, a lid & lash hygiene product that was developed by the Eye Institute and NovaBay Pharmaceuticals (NYSE MKT:NBY) for eye conditions that affect millions of Americans. In addition, an increasing number of those doctors are writing articles describing why Avenova has been so beneficial to patients. “When w
豪雅集团旗下宾得医疗上市用于胃癌早期治疗的 新款多功能内镜粘膜下层剥离器械高频切开刀(Splash M-Knife)
东京–(BUSINESS WIRE)–(美国商业资讯)–豪雅集团旗下宾得医疗上市新款多功能内镜黏膜下剥离器械高频切开刀 (Splash M-Knife)，以实现通过单件器械完成完全性内镜黏膜下剥离术（以下简称ESD）。该新款器械将在日本消化器内视镜学会 (JGES) 第89届年会上展示，该年会将于2015年5月29至31日在日本名古屋召开。 开发可弯曲内窥镜旨在与其他治疗器械一起用于各类微创治疗手术。ESD是十多年前日本发明的一种手术，由于其具有临床和经济效益，有助于早期恢复、降低复杂性和成本，因而已在世界各地普及。 全球产品管理副总裁Rami Liebenthal做出如下评论：“我们正在上市高频切开刀，这是一种创新的多功能ESD器械，它有助于ESD的全球普及，加快胃癌的早期治疗。我们相信，用于精确、高效、更安全ESD的创新器械为开展完全性ESD治疗设立了一个新标准。我们致力于推广该手术及其进一步的开发。” 宾得医疗的高频切开刀具有下列特点。 多功能它可实现清晰的标记、更好的止血、更顺利更轻松的手术，手术过程中无需替换刀具。 独特的机制刀具中的盘片可帮助钩起组织，从而提高安全性
豪雅集團旗下 PENTAX Medical上市用於胃癌早期治療的 新款多功能內視鏡黏膜下剝離器材Splash M-Knife
東京–(BUSINESS WIRE)–(美國商業資訊)–豪雅集團旗下PENTAX Medical上市新款多功能內視鏡黏膜下剝離器材Splash M-Knife，以實現透過單件器材完成完全性內視鏡黏膜下剝離術（以下簡稱ESD）。該新款器材將在日本消化器內視鏡學會(JGES) 第89屆年會上展示，該年會將於2015年5月29至31日在日本名古屋召開。 開發可彎曲內視鏡旨在與其他治療器材一起用於各類微創治療手術。ESD是十多年前日本發明的一種手術，由於其具有臨床和經濟效益，有助於早期恢復、降低複雜性和成本，因而已在世界各地普及。 全球產品管理副總裁Rami Liebenthal做出如下評論：「我們正在上市Splash M-Knife，這是一種創新的多功能ESD器材，它有助於ESD的全球普及，加快胃癌的早期治療。我們相信，用於精確、高效率、更安全ESD的創新器材為展開完全性ESD治療設立了一個新標準。我們致力於推廣該手術及其進一步的開發。」 Splash M-Knife具有下列特點。 多功能它可實現清晰的標記、更好的止血、更順利更輕鬆的手術，手術過程中無需替換刀具。 獨特的機制刀具中的
Ocata Therapeutics Receives Three New U.S. Patents for its RPE Therapy for Macular Degenerative Diseases
MARLBOROUGH, Mass.–(BUSINESS WIRE)–Ocata Therapeutics, Inc. (“Ocata” or “the Company”; NASDAQ: OCAT), a leader in the field of Regenerative Ophthalmology™, today announced that the United States Patent and Trademark Office (USPTO) issued three new U.S. Patents, Nos. 9,040,770, 9,040,039 and 9,040,038, which expand the scope of protection of the four previously issued U.S. patents covering its retinal pigment epithelium (RPE) transplant technology. These three new patents extend protection to
Momentive to Present New Silicone Polymers for Contact Lens Industry
WATERFORD, N.Y.–(BUSINESS WIRE)–Momentive to present two technical posters highlighting the benefits of the new OphthaSil* silicone polymer product portfolio for the contact lens industry.
R-Tech Ueno: Announcement on Completion of the Phase I Single-Dose Clinical Trial for the Novel VAP-1 Inhibitor RTU-1096
TOKYO–(BUSINESS WIRE)–R-Tech Ueno (JASDAQ: 4573) We are pleased to announce that the phase I single-dose clinical trial for the new molecular entity RTU-1096 has been completed. RTU-1096 is a vascular adhesion protein-1 (VAP-1) inhibitor having anti-…
HOYA Group PENTAX Medical Launches Splash M-Knife, the New Multi-Functional ESD Device Contributing in Early Treatment of Gastric Cancer
TOKYO–(BUSINESS WIRE)–PENTAX Medical Launches Splash M-Knife, The New Multi-Functional ESD Device
HOYA株式会社PENTAXライフケア事業部 新製品『PENTAX Medical 高周波ナイフ DN-Dシリーズ （愛称Splash M-Knife）』を販売開始
東京–(BUSINESS WIRE)–HOYA株式会社PENTAXライフケア事業部 新製品『PENTAX Medical 高周波ナイフ DN-Dシリーズ （愛称Splash M-Knife）』を販売開始
Optegra Eye Hospital: Brits Put Bite before Sight New Survey Shows
LONDON–(BUSINESS WIRE)–The demand for a dazzling Hollywood smile could be putting eye health care in the shade according to a new survey released today. While three quarters (75 per cent) of Brits state that sight is the most important of the senses, and 81 per cent say experiencing vision loss would be their biggest concern, latest research reveals we look after our teeth far more than our eyes. In a battle of vision vs. teeth, the eyes should have it. Yet, on average, British adults visit
Kat Graham Set To Appear in Latest Foster Grant Advertising Campaign
SMITHFIELD, R.I.–(BUSINESS WIRE)–FGX International, a leading eyewear designer and marketer, is launching a nationwide consumer ad campaign for its Foster Grant® brand featuring its new spokesperson, popular actress and musician Kat Graham. Kat joins iconic actress and author Brooke Shields as the latest celebrity featured in the brand’s famous “Who’s that behind those Foster Grants®” campaign, which will feature ads on national network cable television as well as a digital component, slated